Raynaud's phenomenon and chronic/recurrent digital ulcers (DU) are main features of systemic sclerosis (SSc). Their treatment includes both systemic (i.e., iloprost) and local therapies. We report the therapeutic effects of iloprost in a cohort of SSc patients during a long-lasting follow-up period.
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study / Colaci, M., Lumetti, F., Giuggioli, D., Guiducci, S., Bellando-Randone, S., Fiori, G., Matucci-Cerinic, M., Ferri, C.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - ELETTRONICO. - 35 Suppl 106:(2017), pp. 179-183.
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study
Guiducci, Serena;Bellando-Randone, Silvia;Fiori, Ginevra;Matucci-Cerinic, Marco;
2017
Abstract
Raynaud's phenomenon and chronic/recurrent digital ulcers (DU) are main features of systemic sclerosis (SSc). Their treatment includes both systemic (i.e., iloprost) and local therapies. We report the therapeutic effects of iloprost in a cohort of SSc patients during a long-lasting follow-up period.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
